Skip to Main Content
Table 2.

Baseline characteristics of evaluable patients (n = 137)

CharacteristicPlacebo (n = 67)Fenretinide (n = 70)
Age (y) mean, median, range 69.2, 70.9, 43.4-84.7 64.5, 64.0, 39.8-87.5 
Gender   
    Male 55 58 
    Female 12 12 
Race   
    Black 
    Hispanic 
    Asian 
    White 59 66 
    Other 
TCC characteristics   
    Ta grade 1, grade 2 (no prior BCG)   
        Solitary 34 33 
        Multifocal 15 17 
    Intermediate-risk, high-risk (prior BCG) 18 20 
Smoking status   
    Current 16 16 
    Former 37 39 
    Never 14 15 
CharacteristicPlacebo (n = 67)Fenretinide (n = 70)
Age (y) mean, median, range 69.2, 70.9, 43.4-84.7 64.5, 64.0, 39.8-87.5 
Gender   
    Male 55 58 
    Female 12 12 
Race   
    Black 
    Hispanic 
    Asian 
    White 59 66 
    Other 
TCC characteristics   
    Ta grade 1, grade 2 (no prior BCG)   
        Solitary 34 33 
        Multifocal 15 17 
    Intermediate-risk, high-risk (prior BCG) 18 20 
Smoking status   
    Current 16 16 
    Former 37 39 
    Never 14 15 
Close Modal

or Create an Account

Close Modal
Close Modal